Literature DB >> 31674073

Long noncoding RNA PCAT-1 knockdown prevents the development of ovarian cancer cells via microRNA-124-3p.

Fengying Min1, Guoyan Chu2.   

Abstract

Long noncoding RNA prostate cancer-associated transcript 1 (PCAT-1) is overexpressed in human malignancies and its silence abates the exaggeration of cancers. Whereas, the activity of PCAT-1 silence in ovarian cancer (OC) remains elusive. Here, our study was designed to corroborate the function of PCAT-1 silence in cellular activities and the molecular mechanisms. PCAT-1 in human ovarian tumor tissue specimens and cell lines (A2780 and SKOV3) were quantified by real-time quantitative reverse polymerase chain reaction (qRT-PCR). Reinforced silence of PCAT-1 and microRNA (miR)-124-3p was established by transfection and identified by qRT-PCR. The viability, apoptosis as well as migration and invasion were examined. Western blot was exploited for analysis of proteins involved in proliferation, apoptosis, migration and invasion, and signaling transduction. OC tissues showed the accumulation of PCAT-1. Silencing PCAT-1 caused the impediment of proliferation, migration, and invasion with the increase in apoptosis. PCAT-1 knockdown repressed the expression of cyclin D1, CDK6, p53, Bax, cleaved caspase-3, metallopeptidases, and vimentin with the restoration of miR-124-3p. However, the roles of PCAT-1 silence were weakened in the absence of miR-124-3p. PCAT-1 silence caused decrease in Wnt3a, β-catenin, and phosphorylation of protein kinase B and mechanistic target of rapamycin was abolished by miR-124-3p inhibitor. The tumor-suppressive role of PCAT-1 silence was mediated by miR-124-3p.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  PCAT-1; apoptosis; miR-124-3p; ovarian cancer

Mesh:

Substances:

Year:  2019        PMID: 31674073     DOI: 10.1002/jcb.29431

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

Review 1.  The potential role of miR-124-3p in tumorigenesis and other related diseases.

Authors:  Qian Li; Shuqing Liu; Jinsong Yan; Ming-Zhong Sun; Frederick T Greenaway
Journal:  Mol Biol Rep       Date:  2021-04-20       Impact factor: 2.316

2.  LEMD1-AS1 Suppresses Ovarian Cancer Progression Through Regulating miR-183-5p/TP53 Axis.

Authors:  Ruowen Guo; Yide Qin
Journal:  Onco Targets Ther       Date:  2020-07-28       Impact factor: 4.147

3.  C-myc/TSPEAR-AS2 Axis Facilitates Breast Cancer Growth and Metastasis in a GLUT1-Dependent Glycolysis Manner.

Authors:  Jian Xu; Tao Li; Yang Zhang; Donghai Qiu; Nan Chen; Xupeng Chai; Jia Li
Journal:  Biomed Res Int       Date:  2022-06-03       Impact factor: 3.246

Review 4.  LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.

Authors:  Eleonora A Braga; Marina V Fridman; Alexey A Moscovtsev; Elena A Filippova; Alexey A Dmitriev; Nikolay E Kushlinskii
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

5.  MiR-4521 plays a tumor repressive role in growth and metastasis of hepatocarcinoma cells by suppressing phosphorylation of FAK/AKT pathway via targeting FAM129A.

Authors:  Munawar Ayesha; Abbasi Majid; Dongting Zhao; Frederick T Greenaway; Naimeng Yan; Qinlong Liu; Shuqing Liu; Ming-Zhong Sun
Journal:  J Adv Res       Date:  2021-05-12       Impact factor: 10.479

6.  Sevoflurane Inhibits lncRNA HOTAIR-Modulated Stability of HK2 mRNA in a m6A-Dependent Manner to Dampen Aerobic Glycolysis and Proliferation in Lung Cancer.

Authors:  Xuefeng Sun; Qiyong Li; Ling Yang
Journal:  Biomed Res Int       Date:  2022-07-06       Impact factor: 3.246

7.  LncRNA LIFR-AS1 overexpression suppressed the progression of serous ovarian carcinoma.

Authors:  Fang Liu; Linyan Cao; Yufang Zhang; Xinyi Xia; Yanhua Ji
Journal:  J Clin Lab Anal       Date:  2022-07-02       Impact factor: 3.124

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.